Skip to main content

Leukemia

Leukemia, Oncology
All-Oral Time-Limited Combination Treatment for CLL or SLL Shows Early Impressive Efficacy
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia, Oncology
Investigational Oral Form of Azacitidine Improves Survival Maintenance Therapy in Patients with Acute Myeloid Leukemia
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia, Oncology
First-Line Acalabrutinib-Based Triplet Therapy Leads to Undetectable Minimal Residual Disease in CLL
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia, Oncology
Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL
Phoebe Starr
Phoebe Starr
Read More
Leukemia, Oncology, Practice Management
First National Study: Geographic Socioeconomic Disparities Mirror Substantial Gaps in Survival in Children with AML
Chase Doyle
Chase Doyle
Read More
In the News, Leukemia, Oncology
November 4, 2019 — Oncology News & Updates
Read More
Leukemia, Oncology
Gilteritinib and CX-01 in the Treatment of Patients with Acute Myeloid Leukemia
Phoebe Starr
Phoebe Starr
Read More
Leukemia, Oncology
Fixed-Duration Targeted Therapy with Venetoclax plus Obinutuzumab New Front-Line Standard for Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Phoebe Starr
Read More
Leukemia, Oncology
First-Line Ibrutinib Improves Outcomes Compared with Current Standard of Care in Older Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia, Oncology
First-Line Enasidenib Achieves Complete Remission in Older Patients with Acute Myeloid Leukemia and IDH2 Mutation
Charles Bankhead
Charles Bankhead
Read More
Page 2 of 7
Results 11 - 20 of 70